Search research articles
Contact Us
Filters
Showing results (1-10 of 126) with videos related to
Page
of 13
Sort By:
Kidney International
|
January 23, 2022
The authors reply
Xiubin Li, Junnan Xu
Advances in Neurobiology
|
September 20, 2014
Glycogenolysis and purinergic signaling
Leif Hertz, Junnan Xu, Liang Peng
International Journal of Surgery (London, England)
|
December 11, 2025
Immune cell phenotypes and triple-negative breast cancer: a mendelian randomization study
Yuhang Zhou, Tao Sun, Junnan Xu
Medcomm
|
March 24, 2025
Bioactive hemostatic materials: a new strategy for promoting wound healing and tissue regeneration
Zhengyuan Liu, Junnan Xu, Xing Wang
Alimentary Pharmacology & Therapeutics
|
March 9, 2026
Letter: Liver Transplantation Outcomes for Alcohol-Associated Liver Disease-Commentary on an Individual Patient Data Meta-Analysis and Future Research Directions
Xinglin Li, Junnan Xu, Chang Liu
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Monarch plus: a research review
Tao Sun, Junnan Xu, Jun Yang
Journal of Cancer
|
October 22, 2019
Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies
Ying Niu, Junnan Xu, Tao Sun
Journal of Cancer
|
July 8, 2021
Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer
Na Wang, Tao Sun, Junnan Xu
Journal of Neuroscience Research
|
August 16, 2014
Regulatory volume increase in astrocytes exposed to hypertonic medium requires β1 -adrenergic Na(+) /K(+) -ATPase stimulation and glycogenolysis
Dan Song, Junnan Xu, Leif Hertz, et al.
Frontiers in Pharmacology
|
August 23, 2018
Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca<sup>2+</sup>]<sub>i</sub>-dependent Activation of Na,K-ATPase/ERK<sub>1/2</sub> Signaling
Junnan Xu, Ye Zhang, Xiangyu Guo, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 126) with videos related to
Sort By:
Page
of 13
Kidney International
|
January 23, 2022
The authors reply
Xiubin Li, Junnan Xu
Advances in Neurobiology
|
September 20, 2014
Glycogenolysis and purinergic signaling
Leif Hertz, Junnan Xu, Liang Peng
International Journal of Surgery (London, England)
|
December 11, 2025
Immune cell phenotypes and triple-negative breast cancer: a mendelian randomization study
Yuhang Zhou, Tao Sun, Junnan Xu
Medcomm
|
March 24, 2025
Bioactive hemostatic materials: a new strategy for promoting wound healing and tissue regeneration
Zhengyuan Liu, Junnan Xu, Xing Wang
Alimentary Pharmacology & Therapeutics
|
March 9, 2026
Letter: Liver Transplantation Outcomes for Alcohol-Associated Liver Disease-Commentary on an Individual Patient Data Meta-Analysis and Future Research Directions
Xinglin Li, Junnan Xu, Chang Liu
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Monarch plus: a research review
Tao Sun, Junnan Xu, Jun Yang
Journal of Cancer
|
October 22, 2019
Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies
Ying Niu, Junnan Xu, Tao Sun
Journal of Cancer
|
July 8, 2021
Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer
Na Wang, Tao Sun, Junnan Xu
Journal of Neuroscience Research
|
August 16, 2014
Regulatory volume increase in astrocytes exposed to hypertonic medium requires β1 -adrenergic Na(+) /K(+) -ATPase stimulation and glycogenolysis
Dan Song, Junnan Xu, Leif Hertz, et al.
Frontiers in Pharmacology
|
August 23, 2018
Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca<sup>2+</sup>]<sub>i</sub>-dependent Activation of Na,K-ATPase/ERK<sub>1/2</sub> Signaling
Junnan Xu, Ye Zhang, Xiangyu Guo, et al.
Page
of 13